Basit öğe kaydını göster

dc.contributor.authorDemir, N.
dc.contributor.authorNadaroglu, H.
dc.contributor.authorOzkan, A.
dc.contributor.authorTasgin, E.
dc.contributor.authorIsik, C.
dc.contributor.authorDemir, Y.
dc.date.accessioned2020-11-20T16:49:13Z
dc.date.available2020-11-20T16:49:13Z
dc.date.issued2014
dc.identifier.issn1872-3128
dc.identifier.urihttps://doi.org/10.2174/1872312808666140514113838
dc.identifier.urihttps://hdl.handle.net/20.500.12809/6116
dc.descriptionPubMed ID: 24826966en_US
dc.description.abstractIn this study, serum samples from 50 patients with the diagnosis of Behcet’s disease and 20 healthy volunteers were analyzed. The study consists of three parts. In the first part, paraoxonase (PON) activities were determined in the serum samples of 50 patients with Behcet’s disease and 20 healthy people. In the second part, equal volumes of serum samples from 50 patients were pooled and PON enzymes were purified by using Sepharose-4B-L-tyrosine tyrosine-1-naphtylamine affinity column. Optimum temperature, optimum pH, Vmax and Km values of the pure enzymes were determined. The same purification procedure was also performed in the serum samples of 20 healthy people. Electrophoretic mobility was observed (via SDS-PAGE) in the PON enzymes that were purified from the serum samples of patients with Behcet’s disease and healthy people. In the third part, in vitro effects of drugs containing azathioprine, methylprednisolone and colchicine that have already been used for the treatment of Behcet’s disease were tested on the PON enzymes of the patients with Behcet’s disease and control group. IC50 values and Ki constant values were measured and inhibition types were determined for the drugs containing azathioprine, methylprednisolone and colchicine that have already been used for the treatment of the Behcet’s disease and demonstrate in vitro inhibition effects. ©2014 Bentham Science Publishers.en_US
dc.item-language.isoengen_US
dc.publisherBentham Science Publishers B.V.en_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAzathioprineen_US
dc.subjectBehcet diseaseen_US
dc.subjectColchicineen_US
dc.subjectMethylprednisoloneen_US
dc.subjectParaoxonaseen_US
dc.subjectPurificationen_US
dc.titlePurification of paraoxonase enzyme from the sera of patients with behcet’s disease and analyzing the effects of the drugs containing imuran (azathioprine), prednisolone (methylprednisolone) and colchium (colchicine)en_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTempDemir, N., Mugla University, Department of Chemistry, Mugla, Turkey; Nadaroglu, H., Ataturk University, Erzurum Vocational and Training School, Department of Food Technology, Erzurum, Turkey; Ozkan, A., Erzurum District Training and Research Hospital, Department of Medical Biochemistry, Erzurum, Turkey; Tasgin, E., Bayburt University, Bayburt, Turkey; Isik, C., Mugla University, Department of Chemistry, Mugla, Turkey; Demir, Y., Mugla University, Department of Chemistry, Mugla, Turkey, M.Akif Ersoy University, Department of Chemistry, Burdur, Turkeyen_US
dc.identifier.doi10.2174/1872312808666140514113838
dc.identifier.volume8en_US
dc.identifier.issue1en_US
dc.identifier.startpage67en_US
dc.identifier.endpage75en_US
dc.relation.journalDrug Metabolism Lettersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster